Clinical trial

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

NCT00210080

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-04-01

PhasePHASE3

Study timeline

Study start (unknown)2001-04-01Date precision: month

Registry last updated2015-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Interventions

Uridine 5'-Triphosphate (UTP) Solution for InhalationDRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00210080 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.